Insulin-like growth factor-1 and insulin-like growth factor binding protein-3: impact on early haematopoietic reconstitution following allogeneic haematopoietic stem cell transplantation

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 : impact on early haematopoietic reconstitution following allogeneic haematopoietic stem cell transplantation. / Weischendorff, Sarah; Sengeløv, Henrik; Juul, Anders; Nielsen, Claus H.; Ryder, Lars P.; Kielsen, Katrine; Müller, Klaus.

In: European Journal of Haematology, Vol. 108, No. 3, 2022, p. 190-198.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Weischendorff, S, Sengeløv, H, Juul, A, Nielsen, CH, Ryder, LP, Kielsen, K & Müller, K 2022, 'Insulin-like growth factor-1 and insulin-like growth factor binding protein-3: impact on early haematopoietic reconstitution following allogeneic haematopoietic stem cell transplantation', European Journal of Haematology, vol. 108, no. 3, pp. 190-198. https://doi.org/10.1111/ejh.13724

APA

Weischendorff, S., Sengeløv, H., Juul, A., Nielsen, C. H., Ryder, L. P., Kielsen, K., & Müller, K. (2022). Insulin-like growth factor-1 and insulin-like growth factor binding protein-3: impact on early haematopoietic reconstitution following allogeneic haematopoietic stem cell transplantation. European Journal of Haematology, 108(3), 190-198. https://doi.org/10.1111/ejh.13724

Vancouver

Weischendorff S, Sengeløv H, Juul A, Nielsen CH, Ryder LP, Kielsen K et al. Insulin-like growth factor-1 and insulin-like growth factor binding protein-3: impact on early haematopoietic reconstitution following allogeneic haematopoietic stem cell transplantation. European Journal of Haematology. 2022;108(3):190-198. https://doi.org/10.1111/ejh.13724

Author

Weischendorff, Sarah ; Sengeløv, Henrik ; Juul, Anders ; Nielsen, Claus H. ; Ryder, Lars P. ; Kielsen, Katrine ; Müller, Klaus. / Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 : impact on early haematopoietic reconstitution following allogeneic haematopoietic stem cell transplantation. In: European Journal of Haematology. 2022 ; Vol. 108, No. 3. pp. 190-198.

Bibtex

@article{9155edb15ec245a5b26872cd123a93cf,
title = "Insulin-like growth factor-1 and insulin-like growth factor binding protein-3: impact on early haematopoietic reconstitution following allogeneic haematopoietic stem cell transplantation",
abstract = "Objectives: The aim of the study was to investigate whether high endogenous levels of insulin-like growth factor-1 (IGF-1) and its binding protein-3 (IGFBP-3) were related to a faster reconstitution of different blood cell populations in the early phase after allogeneic myeloablative haematopoietic stem cell transplantation (HSCT). Methods: We measured IGF-1 and IGFBP-3 by chemiluminescence during the first three weeks after transplantation in 35 adult patients undergoing myeloablative HSCT and calculated area under the curve divided by time (AUC/t) for each patient. Results: Circulating levels of IGF-1 and IGFBP-3 correlated with counts of reticulocytes (rs= 0.44, p =.011 and r = 0.41, p =.017, respectively) and thrombocytes (rs = 0.38, p =.030 and rs = 0.56, p =.0008) three weeks post-transplant. Furthermore, high IGFBP-3 levels correlated with absolute lymphocyte counts 3 weeks post-HSCT (rs = 0.54, p =.012) and were associated with shorter time to neutrophil engraftment (rs = −0.35, p =.043). Both IGF-1 and IGFBP-3 levels were associated with the number of circulating natural killer cells one month after HSCT (rs = 0.42, p =.032 and rs = 0.57, p =.0026). Conclusion: These data indicate that high levels of IGF-1 and IGFBP-3 relate to a faster haematopoietic reconstitution after HSCT and suggest a biological influence of these mediators in haematopoietic homeostasis in these patients.",
keywords = "haematopoiesis, haematopoietic stem cell transplantation, immune reconstitution, insulin-like growth factor binding protein-3, insulin-like growth factor-1",
author = "Sarah Weischendorff and Henrik Sengel{\o}v and Anders Juul and Nielsen, {Claus H.} and Ryder, {Lars P.} and Katrine Kielsen and Klaus M{\"u}ller",
note = "Publisher Copyright: {\textcopyright} 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd",
year = "2022",
doi = "10.1111/ejh.13724",
language = "English",
volume = "108",
pages = "190--198",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Insulin-like growth factor-1 and insulin-like growth factor binding protein-3

T2 - impact on early haematopoietic reconstitution following allogeneic haematopoietic stem cell transplantation

AU - Weischendorff, Sarah

AU - Sengeløv, Henrik

AU - Juul, Anders

AU - Nielsen, Claus H.

AU - Ryder, Lars P.

AU - Kielsen, Katrine

AU - Müller, Klaus

N1 - Publisher Copyright: © 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

PY - 2022

Y1 - 2022

N2 - Objectives: The aim of the study was to investigate whether high endogenous levels of insulin-like growth factor-1 (IGF-1) and its binding protein-3 (IGFBP-3) were related to a faster reconstitution of different blood cell populations in the early phase after allogeneic myeloablative haematopoietic stem cell transplantation (HSCT). Methods: We measured IGF-1 and IGFBP-3 by chemiluminescence during the first three weeks after transplantation in 35 adult patients undergoing myeloablative HSCT and calculated area under the curve divided by time (AUC/t) for each patient. Results: Circulating levels of IGF-1 and IGFBP-3 correlated with counts of reticulocytes (rs= 0.44, p =.011 and r = 0.41, p =.017, respectively) and thrombocytes (rs = 0.38, p =.030 and rs = 0.56, p =.0008) three weeks post-transplant. Furthermore, high IGFBP-3 levels correlated with absolute lymphocyte counts 3 weeks post-HSCT (rs = 0.54, p =.012) and were associated with shorter time to neutrophil engraftment (rs = −0.35, p =.043). Both IGF-1 and IGFBP-3 levels were associated with the number of circulating natural killer cells one month after HSCT (rs = 0.42, p =.032 and rs = 0.57, p =.0026). Conclusion: These data indicate that high levels of IGF-1 and IGFBP-3 relate to a faster haematopoietic reconstitution after HSCT and suggest a biological influence of these mediators in haematopoietic homeostasis in these patients.

AB - Objectives: The aim of the study was to investigate whether high endogenous levels of insulin-like growth factor-1 (IGF-1) and its binding protein-3 (IGFBP-3) were related to a faster reconstitution of different blood cell populations in the early phase after allogeneic myeloablative haematopoietic stem cell transplantation (HSCT). Methods: We measured IGF-1 and IGFBP-3 by chemiluminescence during the first three weeks after transplantation in 35 adult patients undergoing myeloablative HSCT and calculated area under the curve divided by time (AUC/t) for each patient. Results: Circulating levels of IGF-1 and IGFBP-3 correlated with counts of reticulocytes (rs= 0.44, p =.011 and r = 0.41, p =.017, respectively) and thrombocytes (rs = 0.38, p =.030 and rs = 0.56, p =.0008) three weeks post-transplant. Furthermore, high IGFBP-3 levels correlated with absolute lymphocyte counts 3 weeks post-HSCT (rs = 0.54, p =.012) and were associated with shorter time to neutrophil engraftment (rs = −0.35, p =.043). Both IGF-1 and IGFBP-3 levels were associated with the number of circulating natural killer cells one month after HSCT (rs = 0.42, p =.032 and rs = 0.57, p =.0026). Conclusion: These data indicate that high levels of IGF-1 and IGFBP-3 relate to a faster haematopoietic reconstitution after HSCT and suggest a biological influence of these mediators in haematopoietic homeostasis in these patients.

KW - haematopoiesis

KW - haematopoietic stem cell transplantation

KW - immune reconstitution

KW - insulin-like growth factor binding protein-3

KW - insulin-like growth factor-1

U2 - 10.1111/ejh.13724

DO - 10.1111/ejh.13724

M3 - Journal article

C2 - 34741538

AN - SCOPUS:85118852296

VL - 108

SP - 190

EP - 198

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 3

ER -

ID: 288190196